| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.61 | 0.04 |